Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 24096618)

1.

AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.

Sahm F, Bissel J, Koelsche C, Schweizer L, Capper D, Reuss D, Böhmer K, Lass U, Göck T, Kalis K, Meyer J, Habel A, Brehmer S, Mittelbronn M, Jones DT, Schittenhelm J, Urbschat S, Ketter R, Heim S, Mawrin C, Hainfellner JA, Berghoff AS, Preusser M, Becker A, Herold-Mende C, Unterberg A, Hartmann C, Kickingereder P, Collins VP, Pfister SM, von Deimling A.

Acta Neuropathol. 2013 Nov;126(5):757-62. doi: 10.1007/s00401-013-1187-5. Epub 2013 Oct 6.

PMID:
24096618
2.

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.

Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Avşar T, Li J, Murray PB, Henegariu O, Yilmaz S, Günel JM, Carrión-Grant G, Yilmaz B, Grady C, Tanrikulu B, Bakircioğlu M, Kaymakçalan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, Mane S, State MW, Bilgüvar K, Baehring JM, Gutin PH, Piepmeier JM, Vortmeyer A, Brennan CW, Pamir MN, Kiliç T, Lifton RP, Noonan JP, Yasuno K, Günel M.

Science. 2013 Mar 1;339(6123):1077-80. doi: 10.1126/science.1233009. Epub 2013 Jan 24.

3.

Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.

Johnson MD, O'Connell MJ, Pilcher W, Reeder JE.

J Neurosurg. 2010 May;112(5):934-9. doi: 10.3171/2009.7.JNS09726.

PMID:
19698046
4.

NF2 mutations in secretory and other rare variants of meningiomas.

Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A.

Brain Pathol. 2006 Jan;16(1):15-9.

PMID:
16612978
5.

Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.

Girish V, Sachdeva N, Minz RW, Radotra B, Mathuria SN, Arora SK.

Indian J Pathol Microbiol. 2005 Jul;48(3):325-30.

PMID:
16761743
6.

Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.

Durand A, Champier J, Jouvet A, Labrousse F, Honnorat J, Guyotat J, Fèvre-Montange M.

Clin Neuropathol. 2008 Sep-Oct;27(5):334-45.

7.

DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

Menghi F, Orzan FN, Eoli M, Farinotti M, Maderna E, Pisati F, Bianchessi D, Valletta L, Lodrini S, Galli G, Anghileri E, Pellegatta S, Pollo B, Finocchiaro G.

Oncologist. 2011;16(10):1440-50. doi: 10.1634/theoncologist.2010-0249. Epub 2011 Sep 23.

8.

Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.

Trinkaus M, Vranic A, Dolenc VV, Lah TT.

Int J Biol Markers. 2005 Jan-Mar;20(1):50-9.

PMID:
15832773
9.

Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas.

Skiriute D, Tamasauskas S, Asmoniene V, Saferis V, Skauminas K, Deltuva V, Tamasauskas A.

J Neurooncol. 2011 Mar;102(1):89-94. doi: 10.1007/s11060-010-0291-9. Epub 2010 Jul 4.

PMID:
20607352
10.

Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.

Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK, Golubic M.

J Neurosurg. 2001 Jan;94(1):111-7.

PMID:
11147878
11.

Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.

Kim JH, Kim IS, Kwon SY, Jang BC, Suh SI, Shin DH, Jeon CH, Son EI, Kim SP.

Int J Mol Med. 2006 Jul;18(1):27-32.

PMID:
16786152
12.

Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.

Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M, Black PM, Carroll RS, Giovannini M.

Brain Pathol. 2008 Jan;18(1):62-70. Epub 2007 Oct 9.

13.

Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.

Stremenová J, Mares V, Lisá V, Hilser M, Krepela E, Vanicková Z, Syrucek M, Soula O, Sedo A.

Int J Oncol. 2010 Feb;36(2):351-8.

PMID:
20043068
14.

Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas.

Aarhus M, Bruland O, Bredholt G, Lybaek H, Husebye ES, Krossnes BK, Vedeler C, Wester K, Lund-Johansen M, Knappskog PM.

J Neurooncol. 2008 Jul;88(3):251-9. doi: 10.1007/s11060-008-9569-6. Epub 2008 Mar 26.

PMID:
18365142
15.

Differential expression of extracellular matrix-related genes in rare variants of meningioma.

Kwon MJ, Sung CO, Kang SY, Do IG, Suh YL.

Hum Pathol. 2013 Feb;44(2):260-8. doi: 10.1016/j.humpath.2012.05.019. Epub 2012 Sep 17.

PMID:
22995327
16.

Correlation of p63 immunoreactivity with tumor grade in meningiomas.

Rushing EJ, Olsen C, Man YG.

Int J Surg Pathol. 2008 Jan;16(1):38-42. doi: 10.1177/1066896907306772.

PMID:
18203782
17.

Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura.

Johnson MD, O'Connell M.

Hum Pathol. 2013 Jun;44(6):1118-24. doi: 10.1016/j.humpath.2012.09.020. Epub 2013 Jan 11.

PMID:
23317544
18.

Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.

Jabini R, Moradi A, Afsharnezhad S, Ayatollahi H, Behravan J, Raziee HR, Mosaffa F.

Gene. 2014 Apr 1;538(2):348-53. doi: 10.1016/j.gene.2013.12.039. Epub 2014 Jan 5.

PMID:
24398011
19.

p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.

Nozaki M, Tada M, Kashiwazaki H, Hamou MF, Diserens AC, Shinohe Y, Sawamura Y, Iwasaki Y, de Tribolet N, Hegi ME.

Brain Pathol. 2001 Jul;11(3):296-305.

PMID:
11414472
20.

Chromosomal and genetic aberrations differ with meningioma subtype.

Wada K, Maruno M, Suzuki T, Kagawa N, Hashiba T, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T.

Brain Tumor Pathol. 2004;21(3):127-33.

PMID:
15696974
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk